Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

5 Oct 2020

Abstract excerpt

Elevated serum lactate dehydrogenase (sLDH) is associated with poor clinical outcomes in patients with stage IV metastatic melanoma (MM). It is currently unknown if sLDH elevation correlates with distinct molecular, metabolic, or immune features of melanoma metastases. The identification of such features may identify rational therapeutic strategies for patients with elevated sLDH. Thus, we obtained sLDH levels...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33016647
DOI: 10.1002/cam4.3474

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarkerPMID 33016647Read ↗

Unravelling the metabolic landscape of cutaneous melanoma: Insights from single-cell sequencing analysis and machine learning for prognostic assessment of lactate metabolism.Semantic proximity Read ↗

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous MelanomaSemantic proximity Read ↗

Prognostic Significance of mEASIX, Inflammatory–Nutritional Biomarkers, Metastatic Patterns, and Treatment Characteristics in Metastatic Melanoma: A Multicenter Real-World Cohort StudySemantic proximity Read ↗

Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanomaSemantic proximity Read ↗

Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanomaSemantic proximity Read ↗

The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4Semantic proximity Read ↗

Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.Semantic proximity Read ↗

Lactate-Driven Heterogeneity of Immune Checkpoint Expression in Breast and Lung Cancer Cell LinesSemantic proximity Read ↗

Identification of biomarkers of metastatic disease in uveal melanoma using proteomic analysesSemantic proximity Read ↗

LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.Semantic proximity Read ↗

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cellsSemantic proximity Read ↗

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.